Bnp Paribas Asset Management Holding S.A. Vertex Pharmaceuticals Inc Transaction History

Bnp Paribas Asset Management Holding S.A.

  • $41 Billion
  • Q2 2025

A detailed history of Bnp Paribas Asset Management Holding S.A. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Bnp Paribas Asset Management Holding S.A. holds 444,459 shares of VRTX stock, worth $187 Million. This represents 0.48% of its overall portfolio holdings.

Number of Shares
444,459
Previous 392,013 13.38%
Holding current value
$187 Million
Previous $190 Million 4.03%
% of portfolio
0.48%
Previous 0.51%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 05, 2025
BUY
$421.16 - $509.5 $22.1 Million - $26.7 Million
52,446 Added 13.38%
444,459 $198 Million
Q1 2025

May 13, 2025
BUY
$402.49 - $513.76 $948,266 - $1.21 Million
2,356 Added 0.6%
392,013 $190 Million
Q4 2024

Feb 11, 2025
SELL
$396.64 - $516.74 $2.52 Million - $3.29 Million
-6,362 Reduced 1.61%
389,657 $157 Million
Q3 2024

Nov 08, 2024
SELL
$460.0 - $505.78 $5.33 Million - $5.86 Million
-11,591 Reduced 2.84%
396,019 $184 Million
Q2 2024

Jul 29, 2024
SELL
$392.81 - $485.53 $31.1 Million - $38.5 Million
-79,265 Reduced 16.28%
407,610 $191 Million
Q1 2024

May 08, 2024
SELL
$407.69 - $446.08 $46.7 Million - $51.1 Million
-114,639 Reduced 19.06%
486,875 $204 Million
Q4 2023

Feb 09, 2024
SELL
$343.0 - $410.68 $30.4 Million - $36.4 Million
-88,634 Reduced 12.84%
601,514 $245 Million
Q3 2023

Nov 13, 2023
BUY
$338.18 - $362.46 $18 Million - $19.3 Million
53,366 Added 8.38%
690,148 $240 Million
Q2 2023

Aug 08, 2023
SELL
$314.42 - $351.91 $41.8 Million - $46.7 Million
-132,845 Reduced 17.26%
636,782 $224 Million
Q1 2023

May 08, 2023
BUY
$283.23 - $323.1 $27.4 Million - $31.3 Million
96,800 Added 14.39%
769,627 $242 Million
Q4 2022

Feb 09, 2023
BUY
$285.76 - $321.48 $77.4 Million - $87.1 Million
270,921 Added 67.41%
672,827 $194 Million
Q3 2022

Nov 10, 2022
SELL
$273.83 - $305.53 $31.5 Million - $35.2 Million
-115,213 Reduced 22.28%
401,906 $116 Million
Q2 2022

Aug 04, 2022
BUY
$234.96 - $292.55 $2.71 Million - $3.37 Million
11,535 Added 2.28%
517,119 $146 Million
Q1 2022

May 12, 2022
BUY
$221.42 - $260.97 $57.4 Million - $67.6 Million
259,205 Added 105.21%
505,584 $132 Million
Q4 2021

Feb 09, 2022
BUY
$177.01 - $223.45 $7.46 Million - $9.42 Million
42,137 Added 20.63%
246,379 $54.1 Million
Q3 2021

Nov 08, 2021
SELL
$181.39 - $202.99 $16.6 Million - $18.6 Million
-91,765 Reduced 31.0%
204,242 $37 Million
Q2 2021

Aug 05, 2021
SELL
$187.49 - $221.1 $8.41 Million - $9.92 Million
-44,854 Reduced 13.16%
296,007 $59.7 Million
Q1 2021

May 05, 2021
SELL
$207.02 - $241.31 $12.6 Million - $14.7 Million
-60,917 Reduced 15.16%
340,861 $73.2 Million
Q4 2020

Feb 12, 2021
SELL
$207.01 - $276.09 $14.4 Million - $19.2 Million
-69,579 Reduced 14.76%
401,778 $95 Million
Q3 2020

Nov 09, 2020
BUY
$255.65 - $303.1 $12.5 Million - $14.9 Million
49,013 Added 11.6%
471,357 $128 Million
Q2 2020

Aug 04, 2020
BUY
$225.48 - $295.8 $8.85 Million - $11.6 Million
39,257 Added 10.25%
422,344 $123 Million
Q1 2020

May 12, 2020
SELL
$199.77 - $247.81 $15.1 Million - $18.7 Million
-75,427 Reduced 16.45%
383,087 $91.2 Million
Q4 2019

Feb 11, 2020
SELL
$166.71 - $223.91 $10.3 Million - $13.8 Million
-61,714 Reduced 11.86%
458,514 $100 Million
Q3 2019

Nov 12, 2019
BUY
$166.23 - $187.09 $9.14 Million - $10.3 Million
54,976 Added 11.82%
520,228 $88.1 Million
Q2 2019

Aug 02, 2019
BUY
$164.61 - $190.37 $15.1 Million - $17.5 Million
91,768 Added 24.57%
465,252 $85.3 Million
Q1 2019

Apr 26, 2019
BUY
$163.73 - $194.7 $3.21 Million - $3.82 Million
19,618 Added 5.54%
373,484 $68.7 Million
Q4 2018

Feb 13, 2019
SELL
$151.91 - $192.21 $6.83 Million - $8.64 Million
-44,937 Reduced 11.27%
353,866 $57.1 Million
Q3 2018

Nov 13, 2018
BUY
$167.73 - $192.74 $7.73 Million - $8.88 Million
46,095 Added 13.07%
398,803 $76.9 Million
Q2 2018

Aug 01, 2018
BUY
$145.72 - $169.96 $8.57 Million - $10 Million
58,841 Added 20.02%
352,708 $59.9 Million
Q1 2018

May 07, 2018
BUY
$151.6 - $177.13 $4.14 Million - $4.84 Million
27,333 Added 10.25%
293,867 $47.9 Million
Q4 2017

Feb 01, 2018
BUY
$137.28 - $155.55 $10.2 Million - $11.5 Million
74,089 Added 38.5%
266,534 $39.9 Million
Q3 2017

Nov 02, 2017
BUY
$148.13 - $162.24 $28.5 Million - $31.2 Million
192,445
192,445 $29.3 Million

Others Institutions Holding VRTX

# of Institutions
1,787
Shares Held
239M
Call Options Held
1.95M
Put Options Held
1.14M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $108B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Bnp Paribas Asset Management Holding S.A. Portfolio

Follow Bnp Paribas Asset Management Holding S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bnp Paribas Asset Management Holding S.A., based on Form 13F filings with the SEC.

News

Stay updated on Bnp Paribas Asset Management Holding S.A. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email